Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Exact Sciences Corp has a consensus price target of $71.88 based on the ratings of 28 analysts. The high is $90 issued by Bernstein on October 30, 2024. The low is $54 issued by RBC Capital on May 2, 2025. The 3 most-recent analyst ratings were released by Barclays, Barclays, and RBC Capital on June 24, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $64.67 between Barclays, Barclays, and RBC Capital, there's an implied 24.55% upside for Exact Sciences Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/24/2025 | Buy Now | 25.19% | Barclays | Luke Sergott53% | $75 → $65 | Maintains | Overweight | Get Alert |
05/02/2025 | Buy Now | 44.45% | Barclays | Luke Sergott53% | $55 → $75 | Maintains | Overweight | Get Alert |
05/02/2025 | Buy Now | 4.01% | RBC Capital | Gerard Cassidy76% | $52 → $54 | Maintains | Sector Perform | Get Alert |
05/02/2025 | Buy Now | 27.12% | Evercore ISI Group | Vijay Kumar53% | $60 → $66 | Maintains | Outperform | Get Alert |
05/02/2025 | Buy Now | 38.67% | Baird | Catherine Schulte66% | $69 → $72 | Maintains | Outperform | Get Alert |
04/11/2025 | Buy Now | 15.56% | Guggenheim | Subbu Nambi48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
04/10/2025 | Buy Now | 5.93% | Barclays | Luke Sergott53% | $65 → $55 | Maintains | Overweight | Get Alert |
04/10/2025 | Buy Now | 15.56% | Mizuho | Anthony Petrone42% | → $60 | Initiates | → Outperform | Get Alert |
03/13/2025 | Buy Now | 0.15% | RBC Capital | Gerard Cassidy76% | → $52 | Initiates | → Sector Perform | Get Alert |
02/26/2025 | Buy Now | 34.82% | Piper Sandler | David Westenberg62% | $75 → $70 | Maintains | Overweight | Get Alert |
02/24/2025 | Buy Now | 40.6% | Scotiabank | Sung Ji Nam46% | $70 → $73 | Maintains | Sector Outperform | Get Alert |
02/20/2025 | Buy Now | 25.19% | B of A Securities | Derik De Bruin86% | $72 → $65 | Maintains | Buy | Get Alert |
02/20/2025 | Buy Now | 25.19% | Barclays | Luke Sergott53% | $70 → $65 | Maintains | Overweight | Get Alert |
01/23/2025 | Buy Now | 34.82% | Barclays | Luke Sergott53% | → $70 | Initiates | → Overweight | Get Alert |
01/13/2025 | Buy Now | 25.19% | Benchmark | Bruce Jackson36% | $65 → $65 | Reiterates | Buy → Buy | Get Alert |
12/13/2024 | Buy Now | 38.67% | B of A Securities | Derik De Bruin86% | $75 → $72 | Maintains | Buy | Get Alert |
11/26/2024 | Buy Now | 65.64% | TD Cowen | Dan Brennan63% | $82 → $86 | Maintains | Buy | Get Alert |
11/26/2024 | Buy Now | 44.45% | BTIG | Mark Massaro69% | $65 → $75 | Maintains | Buy | Get Alert |
11/11/2024 | Buy Now | 44.45% | Piper Sandler | David Westenberg62% | $85 → $75 | Maintains | Overweight | Get Alert |
11/06/2024 | Buy Now | 44.45% | Citigroup | Patrick Donnelly80% | $80 → $75 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 63.71% | Jefferies | Brandon Couillard42% | $84 → $85 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 25.19% | BTIG | Mark Massaro69% | $82 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 29.04% | Stifel | Daniel Arias79% | $82 → $67 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 44.45% | Canaccord Genuity | Kyle Mikson27% | $95 → $75 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 57.94% | TD Cowen | Dan Brennan63% | $90 → $82 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 25.19% | Goldman Sachs | Matthew Sykes65% | $75 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 15.56% | Evercore ISI Group | Vijay Kumar53% | $80 → $60 | Maintains | Outperform | Get Alert |
11/06/2024 | Buy Now | 25.19% | Craig-Hallum | Alex Nowark62% | $82 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 25.19% | Benchmark | Bruce Jackson36% | $67 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 29.04% | Baird | Catherine Schulte66% | $70 → $67 | Maintains | Outperform | Get Alert |
10/30/2024 | Buy Now | 73.34% | Bernstein | Eve Burstein46% | $75 → $90 | Maintains | Outperform | Get Alert |
10/29/2024 | Buy Now | 82.97% | Canaccord Genuity | Kyle Mikson27% | $75 → $95 | Maintains | Buy | Get Alert |
10/01/2024 | Buy Now | 54.08% | Evercore ISI Group | Vijay Kumar53% | $72 → $80 | Maintains | Outperform | Get Alert |
09/26/2024 | Buy Now | — | Raymond James | Andrew Cooper55% | — | Reiterates | → Market Perform | Get Alert |
09/13/2024 | Buy Now | 44.45% | Canaccord Genuity | Kyle Mikson27% | $75 → $75 | Maintains | Buy | Get Alert |
09/12/2024 | Buy Now | 63.71% | Piper Sandler | David Westenberg62% | $75 → $85 | Maintains | Overweight | Get Alert |
08/27/2024 | Buy Now | 44.45% | Wells Fargo | Brandon Couillard42% | → $75 | Initiates | → Overweight | Get Alert |
08/01/2024 | Buy Now | 29.04% | Benchmark | Bruce Jackson36% | $91 → $67 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | 57.94% | Stifel | Daniel Arias79% | $100 → $82 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 44.45% | Goldman Sachs | Matthew Sykes65% | $88 → $75 | Maintains | Buy | Get Alert |
07/02/2024 | Buy Now | 38.67% | Evercore ISI Group | Vijay Kumar53% | $80 → $72 | Maintains | Outperform | Get Alert |
06/27/2024 | Buy Now | 34.82% | BTIG | Mark Massaro69% | $80 → $70 | Maintains | Buy | Get Alert |
06/27/2024 | Buy Now | 34.82% | Scotiabank | Sung Ji Nam46% | → $70 | Initiates | → Sector Outperform | Get Alert |
06/26/2024 | Buy Now | 34.82% | BTIG | Mark Massaro69% | $80 → $70 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 54.08% | BTIG | Mark Massaro69% | $85 → $80 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 63.71% | Canaccord Genuity | Kyle Mikson27% | $90 → $85 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 54.08% | Citigroup | Patrick Donnelly80% | $100 → $80 | Maintains | Buy | Get Alert |
04/03/2024 | Buy Now | 92.6% | Citigroup | Patrick Donnelly80% | → $100 | Maintains | Buy | Get Alert |
02/22/2024 | Buy Now | 73.34% | Canaccord Genuity | Kyle Mikson27% | $100 → $90 | Maintains | Buy | Get Alert |
01/02/2024 | Buy Now | 75.27% | Benchmark | Bruce Jackson36% | → $91 | Upgrade | Hold → Buy | Get Alert |
12/14/2023 | Buy Now | 73.34% | Guggenheim | Subbu Nambi48% | → $90 | Initiates | → Buy | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel72% | — | Initiates | → Outperform | Get Alert |
11/03/2023 | Buy Now | 73.34% | Goldman Sachs | Matthew Sykes65% | $100 → $90 | Maintains | Buy | Get Alert |
10/16/2023 | Buy Now | 54.08% | Piper Sandler | David Westenberg62% | $90 → $80 | Maintains | Overweight | Get Alert |
10/10/2023 | Buy Now | 73.34% | Piper Sandler | David Westenberg62% | → $90 | Upgrade | Neutral → Overweight | Get Alert |
09/28/2023 | Buy Now | 59.86% | Bernstein | Eve Burstein46% | → $83 | Initiates | → Outperform | Get Alert |
08/08/2023 | Buy Now | 73.34% | Piper Sandler | David Westenberg62% | $80 → $90 | Maintains | Neutral | Get Alert |
08/03/2023 | Buy Now | 111.86% | Jefferies | Brandon Couillard42% | $100 → $110 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 73.34% | Credit Suisse | Dan Leonard60% | $75 → $90 | Maintains | Neutral | Get Alert |
08/02/2023 | Buy Now | 133.05% | Baird | Catherine Schulte66% | $99 → $121 | Maintains | Outperform | Get Alert |
08/02/2023 | Buy Now | — | Benchmark | Bruce Jackson36% | — | Downgrade | Buy → Hold | Get Alert |
07/24/2023 | Buy Now | 111.86% | Goldman Sachs | Matthew Sykes65% | $85 → $110 | Maintains | Buy | Get Alert |
07/21/2023 | Buy Now | 111.86% | Goldman Sachs | Matthew Sykes65% | $85 → $110 | Maintains | Buy | Get Alert |
06/23/2023 | Buy Now | 121.49% | Canaccord Genuity | Kyle Mikson27% | $92 → $115 | Maintains | Buy | Get Alert |
06/22/2023 | Buy Now | 150.39% | Citigroup | Patrick Donnelly80% | $100 → $130 | Maintains | Buy | Get Alert |
06/22/2023 | Buy Now | 84.9% | Benchmark | Bruce Jackson36% | → $96 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 63.71% | Stifel | Daniel Arias79% | → $85 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 77.2% | Canaccord Genuity | Kyle Mikson27% | → $92 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 92.6% | Jefferies | Brandon Couillard42% | $82 → $100 | Maintains | Buy | Get Alert |
05/11/2023 | Buy Now | 92.6% | Citigroup | Patrick Donnelly80% | $90 → $100 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 57.94% | Jefferies | Brandon Couillard42% | $72 → $82 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 69.49% | B of A Securities | Derik De Bruin86% | $80 → $88 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 44.45% | Credit Suisse | Dan Leonard60% | $70 → $75 | Maintains | Neutral | Get Alert |
05/10/2023 | Buy Now | 90.68% | Baird | Catherine Schulte66% | $92 → $99 | Maintains | Outperform | Get Alert |
05/10/2023 | Buy Now | 63.71% | Craig-Hallum | Alex Nowark62% | $55 → $85 | Upgrade | Hold → Buy | Get Alert |
05/05/2023 | Buy Now | 40.6% | UBS | Elizabeth Garcia72% | → $73 | Initiates | → Neutral | Get Alert |
03/15/2023 | Buy Now | 50.23% | Benchmark | Bruce Jackson36% | $54 → $78 | Maintains | Buy | Get Alert |
03/09/2023 | Buy Now | 73.34% | Citigroup | Patrick Donnelly80% | $70 → $90 | Upgrade | Neutral → Buy | Get Alert |
03/03/2023 | Buy Now | 34.82% | Piper Sandler | David Westenberg62% | $50 → $70 | Maintains | Neutral | Get Alert |
02/22/2023 | Buy Now | 46.38% | Cowen & Co. | Dan Brennan63% | $56 → $76 | Maintains | Outperform | Get Alert |
02/22/2023 | Buy Now | 77.2% | Baird | Catherine Schulte66% | $89 → $92 | Maintains | Outperform | Get Alert |
02/22/2023 | Buy Now | 54.08% | BTIG | Mark Massaro69% | $85 → $80 | Maintains | Buy | Get Alert |
02/22/2023 | Buy Now | 44.45% | Canaccord Genuity | Kyle Mikson27% | $70 → $75 | Maintains | Buy | Get Alert |
02/22/2023 | Buy Now | 34.82% | Citigroup | Patrick Donnelly80% | $35 → $70 | Maintains | Neutral | Get Alert |
02/22/2023 | Buy Now | 34.82% | Credit Suisse | Dan Leonard60% | → $70 | Reiterates | → Neutral | Get Alert |
02/10/2023 | Buy Now | 34.82% | Credit Suisse | Dan Leonard60% | $50 → $70 | Downgrade | Outperform → Neutral | Get Alert |
01/18/2023 | Buy Now | — | Raymond James | Andrew Cooper55% | — | Downgrade | Outperform → Market Perform | Get Alert |
01/12/2023 | Buy Now | 44.45% | SVB Leerink | Puneet Souda55% | $70 → $75 | Maintains | Outperform | Get Alert |
01/06/2023 | Buy Now | 34.82% | SVB Leerink | Puneet Souda55% | $60 → $70 | Maintains | Outperform | Get Alert |
12/16/2022 | Buy Now | 34.82% | Jefferies | Brandon Couillard42% | → $70 | Maintains | Buy | Get Alert |
11/14/2022 | Buy Now | -3.7% | Piper Sandler | David Westenberg62% | $40 → $50 | Maintains | Neutral | Get Alert |
11/08/2022 | Buy Now | 15.56% | Raymond James | Andrew Cooper55% | $70 → $60 | Maintains | Outperform | Get Alert |
11/07/2022 | Buy Now | 25.19% | BTIG | Mark Massaro69% | $70 → $65 | Maintains | Buy | Get Alert |
10/19/2022 | Buy Now | — | Craig-Hallum | Alexander Nowak53% | — | Downgrade | Buy → Hold | Get Alert |
08/25/2022 | Buy Now | 5.93% | Credit Suisse | Dan Leonard60% | → $55 | Initiates | → Outperform | Get Alert |
08/17/2022 | Buy Now | -22.96% | Piper Sandler | David Westenberg62% | $50 → $40 | Maintains | Overweight | Get Alert |
08/03/2022 | Buy Now | 15.56% | Craig-Hallum | Alex Nowark62% | $81 → $60 | Maintains | Buy | Get Alert |
08/03/2022 | Buy Now | 29.04% | Cowen & Co. | Dan Brennan63% | $83 → $67 | Maintains | Outperform | Get Alert |
08/03/2022 | Buy Now | 34.82% | BTIG | Mark Massaro69% | $100 → $70 | Maintains | Buy | Get Alert |
08/03/2022 | Buy Now | 44.45% | Baird | Catherine Ramsey59% | $90 → $75 | Maintains | Outperform | Get Alert |
The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Barclays on June 24, 2025. The analyst firm set a price target for $65.00 expecting EXAS to rise to within 12 months (a possible 25.19% upside). 44 analyst firms have reported ratings in the last year.
The latest analyst rating for Exact Sciences (NASDAQ:EXAS) was provided by Barclays, and Exact Sciences maintained their overweight rating.
The last upgrade for Exact Sciences Corp happened on January 2, 2024 when Benchmark raised their price target to $91. Benchmark previously had a hold for Exact Sciences Corp.
The last downgrade for Exact Sciences Corp happened on August 2, 2023 when Benchmark changed their price target from N/A to N/A for Exact Sciences Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exact Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exact Sciences was filed on June 24, 2025 so you should expect the next rating to be made available sometime around June 24, 2026.
While ratings are subjective and will change, the latest Exact Sciences (EXAS) rating was a maintained with a price target of $75.00 to $65.00. The current price Exact Sciences (EXAS) is trading at is $51.92, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.